To address one of the most underestimated public health challenges impacting India’s workforce productivity, the Pragyaan ...

Ltd, Valor Estate Ltd, Pfizer Ltd are among the other stocks to see a surge in volumes on NSE today, 13 November ...

Hyderabad: PRASHO, the Pragyaan Sustainable Health Outcomes Foundation, is partnering with Pfizer to launch Migraine ...

Pfizer has agreed to acquire obesity drug developer Metsera for up to $86.25 a share, surpassing Novo Nordisk's final offer.

India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for its specialty medicine portfolio. The Indian unit of British drugmaker GSK ...

Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its ...

Pfizer Inc. (NYSE: PFE) reported better-than-expected earnings for the third quarter.

The "Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. The ...

OneStep Global's Student Perception Study 2025 reveals that Ireland is rapidly emerging as one of the fastest-growing ...

The DP World Tour staged its inaugural DP World India Championship this week, with a $4 million purse, $680,000 to the winner and a nice turnout from the world's best players. The purse is smaller ...

Pfizer Chief Executive Officer Albert Bourla said that vaccines are harder to get approved right now as Health Secretary Robert F. Kennedy Jr. looks to overhaul the country’s immunization policies.

NEW YORK (Reuters) -Pfizer Chief Executive Albert Bourla said on Tuesday that the U.S. pharmaceutical industry needs to collaborate with China’s, where speedy processes have vaulted it to 30% of ...